{"id":"W4415941623","doi":"10.1016/j.annonc.2025.08.942","title":"519P Real-world effectiveness of 1st line palbociclib + endocrine therapy and subsequent treatments in patients with HR+/HER2- advanced breast cancer: Interim results from the PERFORM study","year":2025,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Advanced Breast Cancer Therapies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Pfizer (Canada)","funders":"","keywords":"Palbociclib; Interim; Second line; Endocrine system; Interim analysis; Line (geometry)","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003463984,0.0002615898,0.0008984289,0.0001675555,0.00004542004,0.000004149232,0.0001595841,0.00005693023,0.00003426912],"category_scores_gemma":[0.00004298432,0.0001604534,0.00006097651,0.000431357,0.0002777802,0.000100326,0.00007745739,0.0002012624,3.937901e-7],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002173507,"about_ca_system_score_gemma":0.0002430013,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006132513,"about_ca_topic_score_gemma":0.004285081,"domain_scores_codex":[0.998189,0.0003178291,0.0005677689,0.0004266254,0.000213484,0.0002853274],"domain_scores_gemma":[0.9980567,0.0007050124,0.0003502092,0.0004484685,0.000378857,0.00006072984],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.06314666,0.002437972,0.661246,0.00004664003,0.0006557159,0.00001429944,0.0009449641,0.00004137264,0.0007202688,0.00001634898,0.000008143929,0.2707216],"study_design_scores_gemma":[0.03552065,0.008864855,0.9464706,0.0007233279,0.00009697179,0.000002446905,0.0005740472,0.000006942377,0.006947947,0.0001137141,0.0005680587,0.0001104272],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9945478,0.0008835594,0.000003506759,0.001879472,0.0001240219,0.001781592,0.0003554266,0.00001780753,0.0004068269],"genre_scores_gemma":[0.9972551,0.001872568,0.00009752494,0.000319532,0.00003803727,0.0002356827,0.00007407139,0.0000242524,0.00008317472],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.2852246,"threshold_uncertainty_score":0.9270566,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0453364453890282,"score_gpt":0.3955320625878051,"score_spread":0.3501956171987769,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}